SPC445
Pegúnígalsídasa alfa-raðbrigðaform af mennskum α-galaktósídasa-A
Status:
UmsóknApplication date:
1.11.2023Application published:
15.12.2023
Max expiry date:
6.9.2036Medicine name:
ElfabrioMedicine for children:
No
Timeline
Today
1.11.2023Application
15.12.2023Publication
6.9.2036Expires
Marketing license
Foreign authorization number:
EU/1/23/1724Date:
4.5.2023
Owner
Name:
Protalix Ltd.Address:
2 Snunit Street Science Park, 2010000 Carmiel IL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3272861
Deadlines
TypeDeadline until
Type: Frestur til að svara höfnun, annar
Deadline until: 22.10.2025